Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

Medchemexpress LLC Pelcitoclax (APG-1252) | 1619923-36-2 | 99.7% | 1281.85 g·mol⁻¹ | C57H66ClF4N6O11PS4 | 5 MG
SDP

Catalog No. 5000264009
Encompass_Preferred

Pelcitoclax is a small-molecule dual inhibitor of Bcl-2 and Bcl-xL used in oncology research. It induces apoptosis and has demonstrated antitumor activity in preclinical models, and is supplied with characterized molecular properties and high analytical purity for research applications.

  • Dual Bcl-2 and Bcl-xL inhibition mechanism
  • Promotes apoptosis in tumor cells
  • Demonstrated antitumor activity in preclinical studies
  • High analytical purity for consistent results
  • Available as solid and ready-to-use DMSO solution formats

Catalog No. 50-002-64009 Supplier Medchemexpress LLC Supplier No. HY1091855MG
May include imposed supplier surcharges.
Add to Cart
Add to Cart

missing translation for 'validMainframeMsg'

Pelcitoclax is a small-molecule dual inhibitor of Bcl-2 and Bcl-xL used in oncology research. It induces apoptosis and has demonstrated antitumor activity in preclinical models, and is supplied with characterized molecular properties and high analytical purity for research applications.

  • Dual Bcl-2 and Bcl-xL inhibition mechanism
  • Promotes apoptosis in tumor cells
  • Demonstrated antitumor activity in preclinical studies
  • High analytical purity for consistent results
  • Available as solid and ready-to-use DMSO solution formats

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.